
Oceanpine Capital
Asia, Hong Kong Island, Hong Kong, Central'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Description
Oceanpine Capital invests in growth equity for innovative companies.
Investor Profile
Oceanpine Capital has made 16 investments, with 0 in the past 12 months and 38% as lead.
Stage Focus
- Series C (44%)
- Series A (19%)
- Series B (19%)
- Series E (6%)
- Series Unknown (6%)
- Seed (6%)
Country Focus
- China (56%)
- United States (44%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Biopharma
- Medical
- Manufacturing
- Clinical Trials
- Artificial Intelligence (Ai)
- Semiconductor
- Electronics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.